KA
SWAV

Kovack Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Kovack Advisors’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-700
Closed -$228K – 610
2024
Q1 		$228K Sell
700
-375
-35% -$92.1K 0.03% 409
2023
Q4 		$205K Sell
1,075
-663
-38% -$125K 0.02% 517
2023
Q3 		$346K Sell
1,738
-651
-27% -$154K 0.05% 350
2023
Q2 		$682K Buy
2,389
+724
+43% +$201K 0.09% 220
2023
Q1 		$361K Buy
1,665
+58
+4% +$11.3K 0.05% 369
2022
Q4 		$330K Buy
1,607
+42
+3% +$10.6K 0.05% 381
2022
Q3 		$435K Sell
1,565
-50
-3% -$12.7K 0.06% 310
2022
Q2 		$309K Sell
1,615
-104
-6% -$18.4K 0.04% 441
2022
Q1 		$356K Buy
1,719
+563
+49% +$92.8K 0.04% 476
2021
Q4 		$206K Sell
1,156
-319
-22% -$62.9K 0.02% 661
2021
Q3 		$304K Buy
1,475
+75
+5% +$14.7K 0.03% 524
2021
Q2 		$266K Sell
1,400
-950
-40% -$155K 0.03% 555
2021
Q1 		$306K Buy
+2,350
New +$282K 0.04% 449

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Kovack Advisors's SWAV Position: Q2 2024 in Review

Kovack Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 700 shares — an estimated $228K sold.

Kovack Advisors first reported a position in SWAV in Q1 2021 and held it in 13 quarters. The position peaked at $682K in Q2 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Kovack Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Kovack Advisors sold 700 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $228K.
  • Kovack Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2021 and held it in 13 quarters.
  • Kovack Advisors's Shockwave Medical, Inc. Common Stock position peaked at $682K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Kovack Advisors's 13F filing for Q2 2024, filed 5 Aug 2024.